Background aims: Corticosteroids are the standard first-line treatment for acute graft-versus-
host disease (aGVHD), but they are associated with many complications, and less than half …

Introduction Although extracorporeal photopheresis (ECP) is a promising second-line
therapy in the treatment of chronic graft-versus-host disease (cGVHD), its use is limited by its …

Abstract Acute Graft-vs.-Host Disease (aGVHD) is the major cause of mortality and morbidity
following allogeneic hematopoietic cell transplantation (AHCT). Steroids are the standard …

Extracorporeal photopheresis (ECP) is an immunomodulatory alternative for treatment of
graft versus host disease (GVHD). The blood is then separated into its various components …

Background and objectives Extracorporeal photopheresis (ECP) is one of the second-line
treatment strategies in steroid-refractory acute graft-versus-host disease (aGvHD). We aimed …

Steroid refractory acute graft-versus-host disease (SR aGvHD) is a major limitation of
successful allogeneic hematopoietic stem cell transplantation (HSCT). Extracorporeal …

Background The safety of extracorporeal photopheresis (ECP) in steroid-refractory chronic
graft-versus-host disease (SR-cGVHD) has been explored in multiple studies but reported …

Chronic GVHD (cGVHD) is a major limitation of allogeneic hematopoietic cell
transplantation. Extracorporeal photopheresis therapy (ECP) has been used in retrospective …

The National Institutes of Health (NIH) classification of graft-versus-host disease (GVHD) is a
significant improvement over prior classifications, and has prognostic implications. We …

Abstract Background & Objectives The primary objective of this observational study was to
perform an exhaustive description concerning patients receiving extracorporeal …